NZ240297A - Synergistic compositions and agents for the treatment of inflammatory or arthritic conditions comprising a 5-lipoxygenase inhibitor and a nsaid - Google Patents

Synergistic compositions and agents for the treatment of inflammatory or arthritic conditions comprising a 5-lipoxygenase inhibitor and a nsaid

Info

Publication number
NZ240297A
NZ240297A NZ240297A NZ24029791A NZ240297A NZ 240297 A NZ240297 A NZ 240297A NZ 240297 A NZ240297 A NZ 240297A NZ 24029791 A NZ24029791 A NZ 24029791A NZ 240297 A NZ240297 A NZ 240297A
Authority
NZ
New Zealand
Prior art keywords
nsaid
inflammatory
agents
treatment
lipoxygenase inhibitor
Prior art date
Application number
NZ240297A
Other languages
English (en)
Inventor
Stephen John Foster
Original Assignee
Ici Plc
Ici Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc, Ici Pharma filed Critical Ici Plc
Publication of NZ240297A publication Critical patent/NZ240297A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ240297A 1990-11-06 1991-10-21 Synergistic compositions and agents for the treatment of inflammatory or arthritic conditions comprising a 5-lipoxygenase inhibitor and a nsaid NZ240297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90403144 1990-11-06

Publications (1)

Publication Number Publication Date
NZ240297A true NZ240297A (en) 1993-11-25

Family

ID=8205772

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ240297A NZ240297A (en) 1990-11-06 1991-10-21 Synergistic compositions and agents for the treatment of inflammatory or arthritic conditions comprising a 5-lipoxygenase inhibitor and a nsaid

Country Status (12)

Country Link
EP (1) EP0485111A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH04264028A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920009396A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU649729B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2054312A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS329691A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE913655A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL99792A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ240297A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT99426A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW216772B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA918387B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029297A1 (en) * 1993-06-07 1994-12-22 Zeneca Limited 2-oxo-1,2,3,4-tetrahydroquinoline derivatives
IL110280A0 (en) * 1993-07-27 1994-10-21 Zeneca Ltd Thiazole derivatives
EP0636624A1 (en) * 1993-07-27 1995-02-01 Zeneca Limited Thiazole derivatives as lipoxygenase inhibitors
ZA945250B (en) * 1993-07-27 1995-01-27 Zeneca Ltd Thiazole derivatives
US5643933A (en) * 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
EP0833622B8 (en) * 1995-06-12 2005-10-12 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
CA2224563A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
US5700816A (en) * 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
DK0880363T3 (da) 1996-02-13 2003-01-20 Searle & Co Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger
ATE296114T1 (de) 1996-02-13 2005-06-15 Searle & Co Zubereitungen, enthaltend einen cyclooxygenase-2- inhibitor und einen leukotrien-b4-rezeptor- antagonisten
DE69709069T2 (de) 1996-02-13 2002-07-04 G.D. Searle & Co., Chicago Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten
US6087446A (en) * 1996-03-20 2000-07-11 Hercules Incorporated Masterbatch formulations for polyolefin applications
US6677364B2 (en) 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
EP0891772A3 (en) * 1997-06-18 1999-05-19 Santen Pharmaceutical Co., Ltd. Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflamatory drug and phenylpropionic acid derivative
EP1385835A1 (en) 2001-04-23 2004-02-04 Astrazeneca AB Benzoxazinone derivatives for use in the treatment of angiogenesis
US7294118B2 (en) 2001-10-24 2007-11-13 Becton, Dickinson And Company Retractable needle assembly
US8377906B2 (en) 2004-06-04 2013-02-19 Ethicon, Inc. Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US8129359B2 (en) 2004-06-04 2012-03-06 Ethicon, Inc. Composition and method for treating post-surgical pain
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
EP2335703B1 (en) 2006-06-13 2014-09-24 Ethicon, Incorporated Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8006488A (nl) * 1979-12-19 1981-07-16 Upjohn Co Werkwijze voor het bereiden van arylpropionzuren.
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
GB9018134D0 (en) * 1989-09-29 1990-10-03 Ici Plc Heterocyclic derivatives
AU637500B2 (en) * 1990-06-21 1993-05-27 Zeneca Limited Bicyclic heterocyclic compounds

Also Published As

Publication number Publication date
IE913655A1 (en) 1992-05-22
TW216772B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-12-01
IL99792A0 (en) 1992-08-18
EP0485111A3 (en) 1993-08-18
AU649729B2 (en) 1994-06-02
JPH04264028A (ja) 1992-09-18
PT99426A (pt) 1992-09-30
AU8604991A (en) 1992-05-14
KR920009396A (ko) 1992-06-25
CA2054312A1 (en) 1992-05-07
CS329691A3 (en) 1992-05-13
EP0485111A2 (en) 1992-05-13
ZA918387B (en) 1992-07-29

Similar Documents

Publication Publication Date Title
NZ240297A (en) Synergistic compositions and agents for the treatment of inflammatory or arthritic conditions comprising a 5-lipoxygenase inhibitor and a nsaid
ZA936659B (en) Corrosion inhibitor compositions
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
AU5590596A (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
HU9202842D0 (en) Climotripsine-type proteases and inhibitors
GB9116684D0 (en) Corrosion inhibitors
EP0390317A3 (en) Corrosion inhibitor and its use
ZA913539B (en) Synergistic therapeutic compositions and methods
ZA925051B (en) Corrosion inhibitors
IL111642A0 (en) Dental prophylaxis and water conservation device
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
GB9009529D0 (en) Biocide composition and use
IL105939A0 (en) Herbicidal compounds and compositions
HUP0104410A3 (en) A composition for the prevention and/or treatment of atherosclerosis
ZA955518B (en) Fungicidal compositions based on 3-phenylpyrazole derivatives for the treatment of plant propagation material new 3-phenylpyrazole derivatives and their fungicidal applications
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
NZ248178A (en) Substituted 4-benzoylisoxazole derivatives and herbicidal compositions thereof
ZA918959B (en) Synergistic herbicidal compositions
NZ312748A (en) Synergistic herbicidal composition and method of use thereof
AU3065492A (en) Corrosion inhibiting method and inhibition compositions
NZ237733A (en) Neutral metalloprotease inhibitors and pharmaceutical compositions
ZA948176B (en) Compositions for the treatment of industrial water
EP0688225A4 (en) METHODS AND COMPOSITIONS FOR INHIBITING COMPLEMENT ACTIVATION
GB9021984D0 (en) Corrosion inhibition
GB2279872B (en) Synergistic herbicidal compositions